ADIPOQ and head and neck squamous cell carcinoma: These studies are consistent with our demonstration of increased adiponectin levels in untreated HNSCC patients and a reduced level in HNSCC patients treated with 1,25(OH)2D3, a treatment that we previously showed to enhance intratumoral immune infiltration and extend the period to post-surgical cancer recurrence [26,35,36].